Choline C-11 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4635 | 94793-58-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 12, 2012 | FDA | MCPRF |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| FDA MoA | N0000000205 | Radiopharmaceutical Activity |
| FDA EPC | N0000177914 | Radioactive Diagnostic Agent |
| CHEBI has role | CHEBI:35207 | radioactive tracer |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| High affinity choline transporter 1 | Transporter | Ki | 6.17 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| CHEBI:72322 | CHEBI |
| CHEMBL2095207 | ChEMBL_ID |
| DB09277 | DRUGBANK_ID |
| DB09563 | DRUGBANK_ID |
| M4AS4XGD4Q | UNII |
| 1425419 | RXNORM |
| 725525002 | SNOMEDCT_US |
| C2698585 | UMLSCUI |
| 449688 | PUBCHEM_CID |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Choline C 11 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52670-556 | INJECTION | 33.10 mCi | INTRAVENOUS | NDA | 25 sections |
| Choline C 11 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52670-556 | INJECTION | 33.10 mCi | INTRAVENOUS | NDA | 25 sections |
| Choline C 11 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 60215-111 | INJECTION | 100 mCi | INTRAVENOUS | ANDA | 16 sections |
| MIC B12 | HUMAN PRESCRIPTION DRUG LABEL | 4 | 70104-806 | INJECTION | 1 mg | INTRAMUSCULAR | unapproved drug other | 1 sections |
| Choline C 11 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 73410-004 | INJECTION | 4 mCi | INTRAVENOUS | ANDA | 24 sections |
| Choline C 11 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 75913-311 | INJECTION | 33.10 mCi | INTRAVENOUS | ANDA | 25 sections |